Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone

Objective: This study compares 3 cohorts of patients with schizophrenia before, during, and after initiating treatment with fluphenazine decanoate (FD), haloperidol decanoate (HD), or long-acting injectable risperidone (LAR). Methods: Administrative data are analyzed from California Medicaid (Medi-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Olfson, Mark, Marcus, Steven C., Ascher-Svanum, Haya
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2007
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779880/
https://www.ncbi.nlm.nih.gov/pubmed/17470444
http://dx.doi.org/10.1093/schbul/sbm033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779880/
https://www.ncbi.nlm.nih.gov/pubmed/17470444
http://dx.doi.org/10.1093/schbul/sbm033

Ejemplares similares